Radioactive injection targets Hard-to-Treat pancreatic tumors
Disease control
Recruiting now
This early-phase trial is testing a radioactive drug called 177Lu-CTR-FAPI in 4 people with advanced pancreatic cancer that has not responded to standard treatments. The drug is given intravenously every 6 weeks for up to 4 doses. Researchers are checking for safety, how much rad…
Phase: EARLY_PHASE1 • Sponsor: Yan Xing • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC